File: 2015-005480-16-information-for-the-public-fr.pdfTrial reference: A Phase 1b Study of Talimogene Laherparepvec in Combination With Atezolizumab in Subjects With Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesDoc type: Information for the public
